sr141716 has been researched along with am 281 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caulder, T; Hoffman, AF; Horti, AG; Katoch-Rouse, R; Mukhin, AG; Pavlova, OA | 1 |
| Dannals, RF; Fan, H; Hoffman, AF; Holt, D; Horti, AG; Hurst, DP; Kotsikorou, E; Lupica, CR; Ravert, HT; Reggio, PH | 1 |
| Arthur, S; Balenga, NA; Henstridge, CM; Irving, AJ; Kargl, JK; Kostenis, E; Martini, L; Penman, J; Platzer, W; Schröder, R; Waldhoer, M; Whistler, JL | 1 |
| Gatley, SJ; Gifford, AN; Lan, R; Makriyannis, A; Tang, Y; Volkow, ND | 1 |
| Bruneus, M; Gatley, SJ; Gifford, AN; Lan, R; Makriyannis, A; Volkow, ND | 1 |
| Capasso, F; Izzo, AA; Mascolo, N; Tonini, M | 1 |
| Cole, RB; Ma, P; Wang, G; Wang, W; Zhang, Q | 1 |
| Pertwee, RG | 1 |
| Bertolini, A; Ferrari, A; Leone, S; Ottani, A; Sandrini, M | 1 |
| Bisogno, T; Di Marzo, V; Gessa, GL; Lutz, B; Marsicano, G; Melis, M; Minassi, A; Muntoni, AL; Perra, S; Petrosino, S; Pillolla, G; Pistis, M | 1 |
| Barnes, S; Jollimore, CA; Kelly, ME; Lalonde, MR; Stevens, K | 1 |
| Goonawardena, AV; Hampson, RE; Pertwee, RG; Riedel, G; Robinson, L | 1 |
| Bátkai, S; Czifra, N; Gerard, NP; Harvey-White, J; Haskó, G; Kunos, G; Liaudet, L; Mukhopadhyay, P; Pacher, P; Rajesh, M; Zsengeller, Z | 1 |
| Bernstein, D; Fajardo, G | 1 |
| Carrión, AM; Delgado-García, JM; Fontanella, GH; Sáez-Cassanelli, JL | 1 |
| Goonawardena, AV; Hampson, RE; Pertwee, R; Platt, B; Riedel, G; Robinson, L | 1 |
| Bátkai, S; Gao, B; Harvey-White, J; Haskó, G; Mackie, K; Mukhopadhyay, B; Mukhopadhyay, P; Pacher, P; Pan, H; Patel, V; Rajesh, M | 1 |
| Haskó, G; Liaudet, L; Mackie, K; Mukhopadhyay, P; Pacher, P; Rajesh, M | 1 |
| Castelli, MP; Ennas, MG; Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M | 1 |
| Brents, LK; Fantegrossi, WE; Franks, LN; Prather, PL; Rajasekaran, M; Seely, KA; Zimmerman, SM | 1 |
| Al-Massadi, O; Baamonde, I; Baltar, J; Barja-Fernandez, S; Casanueva, FF; Castelao, C; Dieguez, C; Folgueira, C; Gonzalez-Saenz, P; Leis, R; Nogueiras, R; Pagotto, U; Pena-Leon, V; Prado, L; Seoane, LM; Tovar, SA | 1 |
1 review(s) available for sr141716 and am 281
| Article | Year |
|---|---|
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.
Topics: Animals; Benzofurans; Cannabinoids; Morpholines; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |
20 other study(ies) available for sr141716 and am 281
| Article | Year |
|---|---|
Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.
Topics: Animals; Benzoxazines; Cannabinoids; Cerebellum; In Vitro Techniques; Ligands; Membrane Potentials; Morpholines; Naphthalenes; Nucleus Accumbens; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Structure-Activity Relationship; Tomography, Emission-Computed | 2003 |
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
Topics: Brain Chemistry; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Piperidines; Positron-Emission Tomography; Protein Binding; Pyrazoles; Radiopharmaceuticals; Receptor, Cannabinoid, CB1; Structure-Activity Relationship | 2009 |
GPR55 ligands promote receptor coupling to multiple signalling pathways.
Topics: Biological Assay; Cannabinoids; Cell Line, Transformed; Endocytosis; Humans; Ligands; Lysophospholipids; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant; Signal Transduction | 2010 |
Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices.
Topics: Acetylcholine; Animals; Benzoxazines; Cannabinoids; Frontal Lobe; Hippocampus; In Vitro Techniques; Iodine Radioisotopes; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rimonabant | 1997 |
Large receptor reserve for cannabinoid actions in the central nervous system.
Topics: Acetylcholine; Analgesics; Animals; Behavior, Animal; Benzoxazines; Calcimycin; Cannabinoids; Hippocampus; Iodine Radioisotopes; Ionophores; Kinetics; Male; Mice; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Tritium | 1999 |
Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; Compliance; Cyclohexanols; Guinea Pigs; Ileum; In Vitro Techniques; Ligands; Male; Morpholines; Muscle Contraction; Naphthalenes; Peristalsis; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2000 |
In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands.
Topics: Animals; Chromatography, High Pressure Liquid; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microsomes, Liver; Morpholines; Piperidines; Pyrazoles; Rats; Receptors, Cannabinoid; Rimonabant | 2005 |
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Dronabinol; Male; Morpholines; Nociceptors; Pain Measurement; Pain Threshold; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2006 |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzoxazines; Brain Ischemia; Cannabinoid Receptor Modulators; Dopamine; Electrophysiology; Endocannabinoids; Glycerides; In Vitro Techniques; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Ventral Tegmental Area | 2006 |
Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Electric Conductivity; Immunohistochemistry; Morpholines; Naphthalenes; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger | 2006 |
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Morpholines; Motor Activity; Neurons; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Space Perception | 2007 |
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cannabinoid Receptor Modulators; Cell Line; DNA Fragmentation; Doxorubicin; Heart Failure; Male; Mice; Mice, Inbred C57BL; Morpholines; Myocardium; Myocytes, Cardiac; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2007 |
Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cannabinoid Receptor Modulators; Doxorubicin; Endocannabinoids; Heart Failure; Morpholines; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2007 |
Functional blockage of the cannabinoid receptor type 1 evokes a kappa-opiate-dependent analgesia.
Topics: Analgesia; Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Hot Temperature; Immunohistochemistry; Male; Mice; Morpholines; Motor Activity; Pain Measurement; Piperidines; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Pyrazoles; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Spinal Cord; Synaptic Transmission | 2007 |
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction.
Topics: Acetylcholine; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cholinergic Antagonists; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Learning Disabilities; Male; Maze Learning; Memory; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine; Spatial Behavior | 2010 |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.
Topics: Animals; Arachidonic Acids; Cell Death; Cisplatin; Disease Models, Animal; Endocannabinoids; Glycerides; Inflammation; Kidney; Male; Mice; Mice, Knockout; Morpholines; Nephritis; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2010 |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
Topics: Acetylcysteine; Arachidonic Acids; Cell Death; Cell Line; Coronary Vessels; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Humans; Mitogen-Activated Protein Kinases; Morpholines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2010 |
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells.
Topics: Action Potentials; Animals; Animals, Newborn; Behavior, Animal; Benzoxazines; Cocaine; Dopamine; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Illicit Drugs; In Vitro Techniques; Male; Mecamylamine; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Neural Inhibition; Neural Pathways; Neurons; Nicotinic Antagonists; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors; Ventral Tegmental Area | 2011 |
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Binding, Competitive; Cannabinoid Receptor Agonists; CHO Cells; Cricetinae; Cricetulus; Drug Inverse Agonism; Humans; Kinetics; Mice; Mice, Inbred Strains; Morpholines; Narcotic Antagonists; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Recombinant Proteins; Rimonabant | 2012 |
Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway.
Topics: Animals; Calcium-Binding Proteins; Cannabinoid Receptor Antagonists; DNA-Binding Proteins; Eating; Enzyme-Linked Immunosorbent Assay; Gastric Mucosa; Male; Models, Animal; Morpholines; Nerve Tissue Proteins; Nucleobindins; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Ribosomal Protein S6 Kinases; Rimonabant; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2017 |